The immunoassay market is entering a period of steady expansion as healthcare systems increasingly prioritize early disease detection, biomarker analysis, personalized medicine, and rapid diagnostic testing. The market was valued at USD 28.0 billion in 2025 and is estimated to reach USD 29.3 billion in 2026, before growing to USD 40.3 billion by 2033. It is projected to expand at a 4.6% CAGR...
The In Vitro Diagnostics Quality Control Market is gaining importance as clinical laboratories and healthcare providers place greater emphasis on accurate, reliable, and consistent diagnostic testing. The market was valued at USD 1.3 billion in 2023 and is projected to grow from USD 1.4 billion in 2026 to USD 1.6 billion by 2030, registering a CAGR of 3.2% from 2024 to 2030. The increasing...
The point of care diagnostics market is gaining momentum as healthcare providers increasingly seek faster, accessible, and efficient diagnostic solutions. According to Grand View Research, the market was valued at USD 21.7 billion in 2025 and is projected to grow from USD 22.6 billion in 2026 to USD 29.9 billion by 2033, registering a CAGR of 4.1% from 2026 to 2033. The ability of point of care...
The autoimmune disease diagnostics market is gaining momentum as the growing burden of autoimmune disorders increases demand for early, accurate, and efficient disease detection. The market was valued at USD 6.1 billion in 2025 and is estimated to reach USD 6.4 billion in 2026. It is projected to expand to USD 9.6 billion by 2033, registering a CAGR of 5.8% from 2026 to 2033.
The increasing...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek